CHI3L1 and central nervous system cancer: In gliomas, CHI3L1 reprograms the tumor microenvironment (TME) by promoting NF-κB pathway activation, regulating tumor malignancy and local invasiveness, making it a potential therapeutic target for gliomas (49, 50).